top of page

New Zealand: Rollout New Life Changing Medicines for Public Health (w.e.f 1 October 2024)

  • Writer: ARQon
    ARQon
  • Oct 30, 2024
  • 1 min read

In a significant advancement in healthcare, Pharmac, Te Aho o Te Kahu | Cancer Control Agency, Ministry of Health and Health New Zealand | Te Whatu Ora, has collaborated in developing a range of new medicines across New Zealand, including cancer medicines. This marks a major milestone for the nation's efforts to improve access to essential treatments for various medical conditions. At the same time, helps to reduce the burden on the healthcare system by providing more effective treatments.

All these medicines have been carefully selected based on their proven efficacy in treating a range of diseases including cancer, cardiovascular disorders, and respiratory conditions. The rollout aims to make vital chronic and life-threatening medications more widely available to New Zealanders regardless of their location or socio-economic status. By enhancing the availability of critical medicines in New Zealand, Te Whatu Ora is taking concrete steps towards reducing health disparities across the country.


Many of the newly introduced medicines represent the latest advancements in pharmaceutical research, offering more targeted treatments. These innovations are paving the way for future developments in personalized medicine and revolutionizing patient care. By providing effective treatments, the healthcare system can prevent the progression of certain diseases, reducing hospital admissions, and improving overall life expectancy.

 

Comentarios


Contact Us

Main Tel:
+65 69090395

Our Company

About ARQon

Our team

Highlights

Address:
221 Henderson Road #02-08,
Henderson Building,
Singapore 159557

Services

Market Readiness
Assistance

ARQon Registration

Attopolis B2B platform

IMDS Training

Global Presence

America

ASEAN

Asia

Middle East

  • LinkedIn
  • Whatsapp
  • X
  • Instagram
  • Facebook
  • Youtube
© 2024 by ARQon
bottom of page